Inspire Medical Systems (INSP) said Monday that it signed a $75 million accelerated share repurchase agreement with Goldman Sachs (GS).
The company said the accelerated share repurchase transaction is scheduled to terminate in Q1 2025 and is under its previously announced $150 million share buyback program, which is set to expire in August 2026.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。